HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
A webcast of the fireside chats will be available on the investor page of Harmony's website at .PLYMOUTH MEETING, Pa., Aug. 21, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in the following upcoming investor conferences:
2024年8月21日，賓夕法尼亞州普利茅斯會議，/專利新聞稿/ - Harmony Biosciences Holdings, Inc. (納斯達克: HRMY) 今天宣佈，Harmony的管理團隊將參加以下即將舉行的投資者會議:
Wells Fargo 2024 Healthcare Conference
2024年富國銀行醫療保健會議
- Location: Boston
- Fireside Chat: Thursday, September 5, 2024, at 9:30 a.m. ET
- 地點: 波士頓
- 火炬聊天:2024年9月5日，東部標準時間上午9:30
2024 Cantor Global Healthcare Conference
2024年甘特全球醫療保健會議
- Location: New York City
- Fireside Chat: Tuesday, September 17, 2024, at 3:05 p.m. ET
- 地點：紐約市
- 火炬聊天:2024年9月17日，東部標準時間下午3:05
A webcast of the fireside chats will be available on the investor page of Harmony's website at .
火炬聊天的網絡廣播將在Harmony網站的投資者頁面上提供。
About Harmony Biosciences
At Harmony Biosciences, we specialize in developing and delivering treatments for rare neurological diseases that others often overlook. We believe that where empathy and innovation meet, a better life can begin for people living with neurological diseases. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, PA, our team of experts from a wide variety of disciplines and experiences is driven by our shared conviction that innovative science translates into therapeutic possibilities for our patients, who are at the heart of everything we do. For more information, please visit .
Harmony生物科學
在Harmony Biosciences，我們專注於開發和推出其他公司常常忽視的罕見神經系統疾病的治療方案。我們相信，同情心和創新相遇之處，對於那些患有神經系統疾病的病人而言，可以開啓更美好的生活。Harmony Biosciences成立於2017年，總部設於賓夕法尼亞州普利茅斯會議（Plymouth Meeting），由Paragon Biosciences，LLC創建。我們擁有來自各種學科和經驗背景的專家團隊，堅信創新科學可以轉化爲對患者的治療可能性，這也是我們所做的一切工作的核心。如需更多信息，請訪問。
Harmony Biosciences Investor Contact:
Brennan Doyle
484-539-9700
[email protected]
Harmony生物科學投資人聯繫方式：
Brennan Doyle
484-539-9700
[email protected]
Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
[email protected]
Harmony生物科學媒體聯繫方式：
凱特·麥坎萊斯（Cate McCanless）
202-641-6086
[email protected]
SOURCE Harmony Biosciences
消息來源：Harmony生物科學